Ligence Heart vs KardiaAI
AI Verdict
Choose Ligence Heart if…
Choose Ligence Heart if your cardiology department requires an AI-powered solution to automate and enhance the analysis and reporting of 2D transthoracic echocardiography. This tool is ideal for improving diagnostic efficiency and accuracy by automatically classifying views, calculating measurements, and recognizing various cardiac diseases directly from echo images, integrating seamlessly with existing PACS and EHR systems.
View Ligence Heart →Choose KardiaAI if…
Choose KardiaAI if you need a robust, FDA-cleared AI software library for the analysis of ambulatory ECG rhythms, particularly for detecting common arrhythmias like AFib, bradycardia, and tachycardia. This tool is best suited for developers and healthcare providers looking to integrate medical-grade ECG analysis capabilities into mobile applications, wearable devices, or other platforms to provide real-time or near real-time heart rhythm insights.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Ligence Heart | KardiaAI |
|---|---|---|
| Pricing | Contact-for-pricing | Subscription-based for advanced features and services. |
| Deployment | Cloud-based; on-premise; hybrid | Mobile app, cloud-based. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Ligence HeartLigence Heart is described as an intuitive, web-based platform that automates complex echocardiography analysis, reducing manual effort and enhancing diagnostic efficiency for cardiologists and sonographers. KardiaAI, as an API library, relies on integration into other applications, making its direct user experience dependent on the host system.
Clinical Value
TieBoth tools provide significant clinical value through FDA-cleared, AI-powered analysis in their respective cardiology domains. Ligence Heart automates comprehensive echocardiography measurements and disease recognition, while KardiaAI offers medical-grade accuracy for a broad range of ECG rhythm detections. Their impact is high but specialized to different diagnostic modalities.
Pricing & Value
KardiaAIKardiaAI offers transparent, subscription-based pricing with clearly defined tiers, allowing potential users to easily understand and compare costs. Ligence Heart's 'contact-for-pricing' and 'enterprise_quote model' make upfront cost assessment less transparent and require direct vendor engagement.
Enterprise Readiness
Ligence HeartBoth tools are FDA-cleared, HIPAA compliant, and have BAAs, indicating readiness for healthcare environments. However, Ligence Heart offers flexible deployment options (cloud, on-premise, hybrid) and explicitly supports integration with critical hospital systems like PACS, EHR, and RIS, suggesting a more comprehensive out-of-the-box enterprise solution.
Innovation
TieBoth tools demonstrate significant innovation in applying AI to cardiology. Ligence Heart's comprehensive automation of complex echocardiography analysis, including image recognition and disease detection, streamlines a traditionally manual process. KardiaAI's API-driven approach for broad-spectrum ECG rhythm analysis offers innovative deployment and accessibility for monitoring.
Support & Docs
KardiaAIKardiaAI (AliveCor) provides a more comprehensive and publicly accessible support ecosystem, including extensive FAQs, multi-language user manuals, direct contact options, and dedicated developer documentation for its API. It also offers an 'AskKardia' AI heart health assistant. Ligence Heart mentions an IFU, installation manual, and training videos, but its overall support structure appears less extensive and publicly detailed.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Ligence Heart | KardiaAI |
|---|---|---|
| Tool Name | Ligence Heart | KardiaAI |
| Company | Ligence | AliveCor |
| Primary Function/Modality | AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms. |
| Key Detections/Analysis | Automated recognition of echocardiography imaging data, view classification, heart phase prediction, measurements, report generation, Area, Distance, Doppler, and Volume quantification, Disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases), Automated strain, Spectral and Tissue Doppler measurements. | AI-powered ECG analysis library, detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE), ECG noise filtering and noisy ECG detection. |
| Integration Capabilities | Integration with existing systems (PACS, EHR, RIS). | API library for integration into other ECG devices and software. |
Videos
Demos, reviews, and walkthroughs featuring Ligence Heart and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring Ligence Heart or KardiaAI
Backers
Who funded each tool's parent company.